Parenteral Drug (India) share news and announcements

BSE: 524689Pharmaceuticals & Biotechnology

Trading suspended since 3 Feb 2025

Last traded ₹2.90 on 21 Aug 2023

Parenteral Drug (India) share news and announcements

782 announcements, routine notices left out, newest first. Page 5 of 16.

Dec 2020
- 8 Dec · Related Party Transactions
  Related Party Transactions on consolidated basis for the half year ending on 30th September, 2020 (opens in a new tab)
- 8 Dec · Disclosure Of Related Party Transactions On Consolidated Basis For The Half Year Ended 30Th September, 2020
  Parenteral Drugs (India) Limited hereby submits disclosure of Related Party Transactions on consolidated basis for the Half year ended 30th September, 2020 (opens in a new tab)
Nov 2020
Oct 2020
- 27 Oct · Compliances- Compliance Certificate For The Period Ended 30Th September 2020
  Parenteral Drugs (India) Limited hereby submits Compliance Certificate under Reg 7(3) of SEBI(LODR)Reg, 2015. (opens in a new tab)
- 24 Oct · Compliances-Regulation 40(10)Certificate
  Parenteral Drugs (India) Limited hereby submits PCS certificate under Regulation 40(10) of SEBI(LODR) Reg, 2015. (opens in a new tab)
- 21 Oct · Shareholding for the Period Ended September 30, 2020
  Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....
- 21 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
- 21 Sep · Corrigendum
  Corrigendum to results of remote e-voting and voting at the 36th Annual General Meeting held on 19th September, 2020 already submitted (opens in a new tab)
- 21 Sep · Corrigendum
  Corrigendum to Scrutinizer Report of 36th Annual General Meeting held on 19th September, 2020 already submitted (opens in a new tab)
- 21 Sep · Results
  Parenteral Drugs (India) Limited hereby submits Corrigendum- Revised disclosure of results of remote e-voting and voting at the 36th Annual General Meeting held on 19th September, 2020 (opens in a new tab)
- 21 Sep · Meeting
  Parenteral Drugs (India) Limited hereby submits Corrigendum Submission of Revised Scrutinizer Report of 36th Annual General Meeting held on 19th September, 2020 (opens in a new tab)
- 21 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 20 Sep · Management
  Reappointment of Mr. Manish Verma, Independent Director for a period of Second Term (opens in a new tab)
- 20 Sep · Management
  Reappointment of Mr. Govind Das Garg (opens in a new tab)
- 20 Sep · Meeting
  Voting results of Annual General Meeting held on September 19, 2020 (opens in a new tab)
- 20 Sep · Meeting
  Copy Srutinizers report of Annual General Meeting held on September 19, 2020 (opens in a new tab)
- 20 Sep · Meeting
  Proceedings of Annual General Meeting held on September 19, 2020 (opens in a new tab)
- 20 Sep · Results
  Parenteral Drugs (India) Limited hereby intimates voting results on business transacted at the 36th Annual General Meeting of the Company held on 19th September, 2020. (opens in a new tab)
- 20 Sep · Meeting
  Parenteral Drugs (India) Limited hereby submits brief proceedings of the 36th Annual General Meeting of the Company held on 19th September, 2020. (opens in a new tab)
- 20 Sep · Meeting
  Parenteral Drugs (India) Limited hereby submits Scrutinizer's Report w.r.t. Voting on agenda items transacted by remote e-voting and voting at the meeting for the 36th Annual General Meeting .... (opens in a new tab)
- 20 Sep · Meeting
  Parenteral Drugs (India) Limited hereby submits outcome of the 36th Annual General Meeting of the Company held on 19th September, 2020. (opens in a new tab)
- 20 Sep · Meeting
  Parenteral Drugs (India) Limited hereby submits outcome of the 36th Annual General Meeting of the Company held on 19th September, 2020. (opens in a new tab)
- 20 Sep · Management
  Parenteral Drugs (India) Limited hereby submit that Mr. Manish Verma (DIN:081685 17), Independent Professional Director of the company have been reappointed held on 19th September, 2020 .... (opens in a new tab)
- 20 Sep · Management
  Parenteral Drugs (India) Limited hereby inform that Mr. Govind Das Garg (DIN: 00520067), Whole Time Director of the company have been reappointed at the Annual General Meeting off the Company .... (opens in a new tab)
Aug 2020
- 29 Aug · Meeting
  Notice of Annual General Meeting to be held on September 19, 2020 - Intimation of notice sent to shareholders in pursuant to Regulation 30 of SEBI (LODR) Regulation , 2015. (opens in a new tab)
- 29 Aug · Announcement under Regulation 30 (LODR)-Meeting Updates
  Parenteral Drugs (India ) Limited hereby intimate regarding notice of 36th AGM sent to shareholders. (opens in a new tab)
- 28 Aug · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from 14-Sep-2020 to 19-Sep-2020 for the purpose of Annual General Meeting. (opens in a new tab)
- 28 Aug · Reg. 34 (1) Annual Report
  Parenteral Drugs (India) Limited hereby submits Annual Report for the Financial Year 2019-20 (opens in a new tab)
- 28 Aug · Updates
  'Intimation regarding Book Closure .'.from 14th September 2020 to 19th September 2020. (opens in a new tab)
- 28 Aug · Meeting
  Parenteral Drugs (India) Limited hereby submits the Notice of 36th Annual General Meeting scheduled to be held on 19th September, 2020 (opens in a new tab)
- 28 Aug · Meeting
  Parenteral Drugs (India) Limited hereby inform the period for Book Closure to the Exchange for the purpose of Annual General Meeting from 14th September, 2020 to 19th September, 2020 (opens in a new tab)
- 28 Aug · Meeting
  Notice of Annual General Meeting to be held on September 19, 2020 (opens in a new tab)
- 27 Aug · Related Party Transactions
  Disclosure of Related Party Transactions on consolidated basis for the half year ended on 31st March, 2020 (opens in a new tab)
- 27 Aug · Disclosure Of Related Party Transactions For The Half Year Ended March, 2020
  Parenteral Drugs (India) Limited hereby submits disclosure of Related Party transactions on consolidated basis for the half year ended March, 2020 in accordance with Regulation 23(9) of .... (opens in a new tab)
- 25 Aug · Results
  Financial results for the period ended June 30, 2020. (opens in a new tab)
- 25 Aug · Results
  Parenteral Drugs (India) Limited hereby submits Unaudited Financial Results of the Company (on both Standalone and Consolidated basis) for the quarter ended 30th June, 2020 (opens in a new tab)
- 25 Aug · Limited Review Report
  Limited Review Report for the Quarter ended Jun 30, 2020 (opens in a new tab)
- 25 Aug · Results
  Parenteral Drugs (India ) Limited hereby submits Quarterly Unaudited Financial Results (on both Standalone and Consolidated basis) of the Company for the financial year 2020-21 ended on 30th June, 2020. (opens in a new tab)
- 25 Aug · Board meeting
  Board meeting held on August 25, 2020. (opens in a new tab)
- 25 Aug · Board meeting
  Board inter-alia considered, approved and took on record the Quarterly Unaudited Financial Statements (on both Standalone and Consolidated basis) of the Company for the financial year .... (opens in a new tab)
- 19 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2020 and other business matters (opens in a new tab)
- 19 Aug · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2020 ,inter alia, to consider and approve unaudited (provisional) .... (opens in a new tab)
Jul 2020
- 29 Jul · Results
  Financial results for the period ended March 31, 2020. (opens in a new tab)
- 29 Jul · Results
  Parenteral Drugs (India) Limited hereby submits Audited Annual Financial Results on both standalone and consolidated basis for the quarter and year ended 31st March, 2020. (opens in a new tab)